adlab med ltd Company Information
Company Number
08184958
Website
-Registered Address
7 holly road, orpington, BR6 6BE
Industry
Specialist medical practice activities
Telephone
-
Next Accounts Due
112 days late
Group Structure
View All
Shareholders
adebayo adefunminiyi anjorin 40%
olayemi omolara anjorin 40%
View Alladlab med ltd Estimated Valuation
Pomanda estimates the enterprise value of ADLAB MED LTD at £133.5k based on a Turnover of £221.2k and 0.6x industry multiple (adjusted for size and gross margin).
adlab med ltd Estimated Valuation
Pomanda estimates the enterprise value of ADLAB MED LTD at £0 based on an EBITDA of £-588 and a 4.58x industry multiple (adjusted for size and gross margin).
adlab med ltd Estimated Valuation
Pomanda estimates the enterprise value of ADLAB MED LTD at £0 based on Net Assets of £-11.8k and 0.39x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Adlab Med Ltd Overview
Adlab Med Ltd is a live company located in orpington, BR6 6BE with a Companies House number of 08184958. It operates in the specialists medical practice activities sector, SIC Code 86220. Founded in August 2012, it's largest shareholder is adebayo adefunminiyi anjorin with a 40% stake. Adlab Med Ltd is a established, micro sized company, Pomanda has estimated its turnover at £221.2k with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
Adlab Med Ltd Health Check
Pomanda's financial health check has awarded Adlab Med Ltd a 1 rating. We use a traffic light system to show it exceeds the industry average on 0 measures and has 3 areas for improvement. Company Health Check FAQs
0 Strong
3 Regular
3 Weak
Size
annual sales of £221.2k, make it smaller than the average company (£337.2k)
- Adlab Med Ltd
£337.2k - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Adlab Med Ltd
- - Industry AVG
Production
with a gross margin of 58%, this company has a comparable cost of product (58%)
- Adlab Med Ltd
58% - Industry AVG
Profitability
an operating margin of -0.3% make it less profitable than the average company (19%)
- Adlab Med Ltd
19% - Industry AVG
Employees
with 3 employees, this is below the industry average (9)
3 - Adlab Med Ltd
9 - Industry AVG
Pay Structure
on an average salary of £27k, the company has an equivalent pay structure (£27k)
- Adlab Med Ltd
£27k - Industry AVG
Efficiency
resulting in sales per employee of £73.7k, this is equally as efficient (£73.7k)
- Adlab Med Ltd
£73.7k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- Adlab Med Ltd
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- Adlab Med Ltd
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Adlab Med Ltd
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Adlab Med Ltd
- - Industry AVG
Debt Level
There is insufficient data available for this Key Performance Indicator!
- - Adlab Med Ltd
- - Industry AVG
ADLAB MED LTD financials
Adlab Med Ltd's latest turnover from August 2022 is estimated at £221.2 thousand and the company has net assets of -£11.8 thousand. According to their latest financial statements, Adlab Med Ltd has 3 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Aug 2022 | Aug 2021 | Aug 2020 | Aug 2019 | Aug 2018 | Aug 2017 | Aug 2016 | Aug 2015 | Aug 2014 | Aug 2013 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | ||||||||||
Other Income Or Grants | ||||||||||
Cost Of Sales | ||||||||||
Gross Profit | ||||||||||
Admin Expenses | ||||||||||
Operating Profit | ||||||||||
Interest Payable | ||||||||||
Interest Receivable | ||||||||||
Pre-Tax Profit | ||||||||||
Tax | ||||||||||
Profit After Tax | ||||||||||
Dividends Paid | ||||||||||
Retained Profit | ||||||||||
Employee Costs | ||||||||||
Number Of Employees | 3 | 3 | 3 | |||||||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Aug 2022 | Aug 2021 | Aug 2020 | Aug 2019 | Aug 2018 | Aug 2017 | Aug 2016 | Aug 2015 | Aug 2014 | Aug 2013 | |
---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 482 | 951 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 4,855 | 0 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 0 | 0 | 0 | 0 | 4,855 | 0 | 0 | 0 | 482 | 951 |
Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Debtors | 0 | 0 | 0 | 0 | 0 | 2,155 | 0 | 0 | 0 | 4,621 |
Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Misc Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 6,053 | 6,922 | 0 | 0 |
Cash | 0 | 237 | 3,046 | 327 | 0 | 9,828 | 13,483 | 5,791 | 20,484 | 11,357 |
misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current assets | 0 | 237 | 3,046 | 327 | 0 | 11,983 | 19,536 | 12,713 | 20,484 | 15,978 |
total assets | 0 | 237 | 3,046 | 327 | 4,855 | 11,983 | 19,536 | 12,713 | 20,966 | 16,929 |
Bank overdraft | 363 | 0 | 0 | 0 | 885 | 0 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 0 | 0 | 0 | 0 | 0 | 0 | 19,399 | 12,614 | 12,109 | 16,835 |
Group/Directors Accounts | 10,883 | 10,883 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 600 | 600 | 1,487 | 600 | 600 | 2,114 | 0 | 0 | 0 | 0 |
total current liabilities | 11,846 | 11,483 | 1,487 | 600 | 1,485 | 2,114 | 19,399 | 12,614 | 12,109 | 16,835 |
loans | 0 | 0 | 6,500 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other liabilities | 0 | 0 | 0 | 0 | 0 | 9,805 | 0 | 0 | 0 | 0 |
provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total long term liabilities | 0 | 0 | 6,500 | 0 | 0 | 9,805 | 0 | 0 | 0 | 0 |
total liabilities | 11,846 | 11,483 | 7,987 | 600 | 1,485 | 11,919 | 19,399 | 12,614 | 12,109 | 16,835 |
net assets | -11,846 | -11,246 | -4,941 | -273 | 3,370 | 64 | 137 | 99 | 8,857 | 94 |
total shareholders funds | -11,846 | -11,246 | -4,941 | -273 | 3,370 | 64 | 137 | 99 | 8,857 | 94 |
Aug 2022 | Aug 2021 | Aug 2020 | Aug 2019 | Aug 2018 | Aug 2017 | Aug 2016 | Aug 2015 | Aug 2014 | Aug 2013 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | ||||||||||
Operating Profit | ||||||||||
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 482 | 469 | 469 |
Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax | ||||||||||
Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors | 0 | 0 | 0 | -4,855 | 2,700 | -3,898 | -869 | 6,922 | -4,621 | 4,621 |
Creditors | 0 | 0 | 0 | 0 | 0 | -19,399 | 6,785 | 505 | -4,726 | 16,835 |
Accruals and Deferred Income | 0 | -887 | 887 | 0 | -1,514 | 2,114 | 0 | 0 | 0 | 0 |
Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash flow from operations | ||||||||||
Investing Activities | ||||||||||
capital expenditure | ||||||||||
Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
cash flow from investments | ||||||||||
Financing Activities | ||||||||||
Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 0 | 10,883 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term loans | 0 | -6,500 | 6,500 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | 0 | 0 | 0 | 0 | -9,805 | 9,805 | 0 | 0 | 0 | 0 |
share issue | ||||||||||
interest | ||||||||||
cash flow from financing | ||||||||||
cash and cash equivalents | ||||||||||
cash | -237 | -2,809 | 2,719 | 327 | -9,828 | -3,655 | 7,692 | -14,693 | 9,127 | 11,357 |
overdraft | 363 | 0 | 0 | -885 | 885 | 0 | 0 | 0 | 0 | 0 |
change in cash | -600 | -2,809 | 2,719 | 1,212 | -10,713 | -3,655 | 7,692 | -14,693 | 9,127 | 11,357 |
adlab med ltd Credit Report and Business Information
Adlab Med Ltd Competitor Analysis
Perform a competitor analysis for adlab med ltd by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other micro companies, companies in BR6 area or any other competitors across 12 key performance metrics.
adlab med ltd Ownership
ADLAB MED LTD group structure
Adlab Med Ltd has no subsidiary companies.
Ultimate parent company
ADLAB MED LTD
08184958
adlab med ltd directors
Adlab Med Ltd currently has 3 directors. The longest serving directors include Mrs Olayemi Anjorin (Aug 2012) and Dr Adebayo Anjorin (Aug 2012).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mrs Olayemi Anjorin | England | 55 years | Aug 2012 | - | Director |
Dr Adebayo Anjorin | England | 57 years | Aug 2012 | - | Director |
Miss Adedolapo Anjorin | England | 30 years | Aug 2012 | - | Director |
P&L
August 2022turnover
221.2k
+7%
operating profit
-588
0%
gross margin
58.1%
+4.46%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
August 2022net assets
-11.8k
+0.05%
total assets
0
-1%
cash
0
-1%
net assets
Total assets minus all liabilities
adlab med ltd company details
company number
08184958
Type
Private limited with Share Capital
industry
86220 - Specialist medical practice activities
incorporation date
August 2012
age
12
incorporated
UK
accounts
Total Exemption Full
ultimate parent company
previous names
N/A
last accounts submitted
August 2022
address
7 holly road, orpington, BR6 6BE
accountant
LEKOD CONSULTING LTD
auditor
-
adlab med ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to adlab med ltd.
adlab med ltd Companies House Filings - See Documents
date | description | view/download |
---|